Clinical trial NCT06765278: Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries
Official title: Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group (PENG) Block Versus Interscalene Brachial Plexus (ISB) Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Anterior Glenoid Nerve Block
Pericapsular Nerve Group Block
Interscalene Brachial Plexus Block
Postoperative Pain
Shoulder Arthroscopic Surgeries
Lead sponsor: Ain Shams University
Sponsor class: OTHER
First posted: 2025-01-09
Enrollment: 49
Sex: ALL
Minimum age (years): 18
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study aims to compare between Anterior glenoid nerve block, pericapsular nerve group (PENG) block and Interscalene brachial plexus (ISB) block for post-operative pain management in shoulder arthroscopic surgeries

Detailed description: Major surgeries of the shoulder constitute some of the most commonly performed orthopedic procedures. They often result in moderate to severe postoperative pain thereby requiring a multimodal analgesic approach centered around peripheral nerve blocks.

Postoperative pain management is the part of shoulder surgery to improve patient satisfaction, start rehabilitation process rapidly and decrease for hospital stay.

Interscalene blocks (ISB) are well-studied and established means of providing analgesia following shoulder surgery and are considered the gold standard mode of regional anesthesia and post-operative pain management in shoulder surgeries.

A novel technique: pericapsular nerve group (PENG) block can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. In addition, PENG block targets articular branches with less motor effect compared with interscalene brachial plexus block providing anesthetic and analgesic effect with less complication and better and sooner ambulation.

Eligibility criteria: Inclusion Criteria:

* Age from 18 to 70 years.
* No sex predilection.
* American Society of Anesthesiology (ASA) physical status I-II.
* Undergoing shoulder arthroscopic surgeries.

Exclusion Criteria:

* Patient's refusal.
* Patients with a history of drug allergies to study drugs.
* Evidence of local infection at the site of injection.
* Inability to cooperate
* Neuromuscular pathology (example: - Multiple Sclerosis)
* Previous trauma or surgery to the shoulder

Primary outcomes:
measure: Time to the 1st rescue analgesia
timeFrame: 24 hours postoperatively
Secondary outcomes:
measure: Total pethidine consumption
timeFrame: 24 hours postoperatively
measure: Degree of pain
timeFrame: 24 hours postoperatively
measure: Length of hospital stay
timeFrame: Till discharge from hospital (Up to one week).
measure: Time needed for the patient to freely move the operated limb
timeFrame: Postoperatively (Up to one week).
measure: Degree of patients satisfaction
timeFrame: 24 hours postoperatively
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: Ain Shams University
Study officials:
References: